Disease Info Card

Mucinous Adenocarcinoma

Information about Mucinous Adenocarcinoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Mucinous Adenocarcinoma

Most recent studies have shown that Mucinous Adenocarcinoma shares some biological mechanisms with adenocarcinoma, adenoma, carcinoma, colonic-neoplasms, hyperplasia, infective-disorder, inflammation, lymphatic-metastasis, malignant-neoplasm-of-breast, malignant-neoplasm-of-stomach, malignant-neoplasms, malignant-paraganglionic-neoplasm, mammary-neoplasms, metaplasia, neoplasm-metastasis, neoplasms, ovarian-neoplasm, pancreatic-neoplasm, stomach-neoplasms, ulcer.

Among the many pathways, these few ones have gauged particular interests from scientists studying Mucinous Adenocarcinoma, and have been seen in publications frequently: Acid Secretion, Cell Differentiation, Cell Proliferation, Coagulation, Excretion, Exocytosis, Hypersensitivity, Immune Response, Inflammatory Response, Innervation, Localization, Mucus Secretion, Pathogenesis, Pigmentation, Reflex, Regeneration, Secretion, Sensitization, Transport, Virulence

Quite a number of genes have been found to play important roles in Mucinous Adenocarcinoma, such as CEACAM5, CEACAM7, EGF, EGFR, ERBB2, IL13, KRT20, KRT7, MUC1, MUC2, MUC5AC, MUC5B, PCNA, PGR, PSG2, TFF2, TNF, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.